A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä

Prodrug approaches of nucleotides and oligonucleotides




TekijätPoijarvi-Virta P, Lonnberg H

KustantajaBENTHAM SCIENCE PUBL LTD

Julkaisuvuosi2006

Lehti:Current Medicinal Chemistry

Tietokannassa oleva lehden nimiCURRENT MEDICINAL CHEMISTRY

Lehden akronyymiCURR MED CHEM

Vuosikerta13

Numero28

Aloitussivu3441

Lopetussivu3465

Sivujen määrä25

ISSN0929-8673

DOIhttps://doi.org/10.2174/092986706779010270


Tiivistelmä
The main threshold for the therapeutic applications of nucleotides and oligonucleotides is their ionic structure which implies poor cellular uptake and unfavorable pharmacokinetic parameters. To circumvent these problems, the anionic phosphate moieties may be temporarily masked with enzymolabile protecting groups to form neutral pronucleotides or pro-oligonucteotides. In cells, enzymes cleave the protecting groups and release the parent drug. Several prodrug strategies have been developed, but the kinetics and mechanisms of the deprotection of potential prodrug candidates are still often poorly known. The purpose of the present review is to summarize the current knowledge on the chemical aspects of alternative prodrug strategies at nucleotide and oligonucleotide level.


Research Areas



Last updated on 2025-14-10 at 09:58